Labshake search
Citations for R&D Systems :
1 - 50 of 3450 citations for 1 2 Chloropyridin 3 yl 3 3 dimethylazetidin 2 one since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2024Quote: ... from 2-3 donors towards CXCL2 (R&D Systems, cat. 276-GB-010) and RARRES2 (R&D Systems ...
-
bioRxiv - Immunology 2023Quote: ... 2 ng/mL of IL-2 and 3 ng/mL of TGFβ (R&D systems, 7666-MB-055)) conditions ...
-
bioRxiv - Cancer Biology 2022Quote: ... Digested cells were washed three times with PBS and resuspended in 2/3 Cultrex Type 2 (R&D Systems) and 1/3 Full Ad-DF+++ medium and plated in drops which were allowed to solidify for 30 minutes at 37°C after which they were overlayed with Full Ad-DF+++ medium ...
-
bioRxiv - Genetics 2021Quote: ... 3 ng/ml mouse IL-3 (R&D Systems) and 20% L-cell conditioned medium ...
-
Low-dose cytokine immunotherapy of solid cancers enabled by phagocytic-competent protein co-crystalsbioRxiv - Cancer Biology 2023Quote: ... 3 and 6 days and subsequently tested by IL-2 ELISA (R&D Systems) according to the manufacturer’s protocol.
-
bioRxiv - Genomics 2024Quote: ... M anti-DENV NS1 (Type 2/3/4) (Cat# MAB94441-100, R&D Systems), M anti-NXT1 (Cat#67680-1-Ig ...
-
bioRxiv - Molecular Biology 2020Quote: Randomly selected sections coming from ovarian tissue of least 3 different individuals were used for immunohistochemistry for Anti-active Caspase-3 (AC-3, 1:1000, AF-835, R&D Systems), γH2AX (1:250 IHC-00059 ...
-
bioRxiv - Neuroscience 2022Quote: ... and Neurotrophin-3 (NT-3, 20ng/ml, R&D systems) were used for neural differentiation between days 27 and 41 ...
-
bioRxiv - Neuroscience 2021Quote: ... PlGF-2 (3 – 30 ng; 5 µl; cat.465-PL/CF, R&D System, USA), VEGF-E (3 – 30 ng ...
-
bioRxiv - Bioengineering 2022Quote: ... and interleukin-3 (IL-3) were purchased from R&D Systems.
-
bioRxiv - Cancer Biology 2022Quote: ... human interleukin-3 (IL-3, 10 ng/mL, R&D Systems), human interleukin-6 (IL-6 ...
-
bioRxiv - Bioengineering 2020Quote: ... Mouse IL-28 A/B (IFN-lambda 2/3) Du-oSet ELISA (DY1789B, R&D Systems), was used to assess cross-reactivity.
-
bioRxiv - Pathology 2020Quote: ... goat polyclonal anti YM1/Chitinase-3 like 3 (R&D systems, Cat. No. AF2446, 1:400 dilution). Antigen retrieval of HIER2 (EDTA ...
-
bioRxiv - Cancer Biology 2021Quote: Cells were grown to 70% confluent in 24-well plates prior to treatment with N-[2-[[3-(4-Bromophenyl)-2-propenyl]amino]ethyl]-5-isoquinolinesulfonamide dihydrochloride (H89; R&D Systems) or 3-(1,3-Benzodioxol-5-ylmethylene)-2-oxo-1-pyrrolidinecarboxaldehyde (KNK437 ...
-
bioRxiv - Developmental Biology 2021Quote: ... 3 µM ZM306416 (R&D Systems, 2499/1) and 10 µM of SU5402 (R&D Systems ...
-
bioRxiv - Physiology 2022Quote: ... rhuIL-3 (1 ng/ml, R&D Systems). Erythropoiesis was induced by addition of 3 U/ml recombinant human erythropoietin (rEPO ...
-
bioRxiv - Cancer Biology 2022Quote: ... Caspase 3 (R&D Systems AF835, 1:800). The sections were then incubated with appropriate secondary antibodies for 30 minutes at room temperature ...
-
bioRxiv - Developmental Biology 2020Quote: ... or Tgfb1/2/3 ligands (10ng/ml, each) (R&D systems, 240-B/302-B2/243-B3) was placed in the upper and lower chambers ...
-
bioRxiv - Molecular Biology 2024Quote: ... 10 ng/mL mouse interleukin-3 (IL-3) (R&D Systems, 403-ML) and 10 ng/mL mouse interleukin-6 (IL-6 ...
-
bioRxiv - Cancer Biology 2021Quote: ... active caspase-3 (R&D Systems AF835; 1:50), and Vimentin (CST 5741 ...
-
bioRxiv - Cancer Biology 2021Quote: ... and caspase-3 (1:2000, AF835, R&D Systems) on a Ventana Benchmark Ultra automated staining system (Roche) ...
-
bioRxiv - Developmental Biology 2023Quote: ... VEGFR-3 (AF349, R&D Systems, 1:100, RRID:AB_355314), Coup-TF2 (EPR18443 ...
-
bioRxiv - Cell Biology 2023Quote: ... GLI-3 (AF3690, R&D Systems, dilution 1:500), RAB11FIP5 (14594-1-AP ...
-
bioRxiv - Cell Biology 2023Quote: ... anti-Galectin-3 (1:50; R&D systems, AF1197), anti-Hsp70 (1:300 ...
-
bioRxiv - Cell Biology 2023Quote: ... and 1 ng/ml IL-3 (R&D Systems) to induce cell proliferation ...
-
bioRxiv - Bioengineering 2022Quote: ... α3 (MAB1345; R&D systems), β4 (NBP1-43369) ...
-
bioRxiv - Cancer Biology 2024Quote: ... Type 3 (R&D Systems); coenzyme Q10 (CoQ) ...
-
bioRxiv - Cancer Biology 2024Quote: ... one million cells were suspended in 100 µl of 1:1 RPMI and BME-Type 3 (R&D Systems, # 36-320-1002P) per implantation ...
-
bioRxiv - Cell Biology 2021Quote: ... cleaved Caspase 3 (rabbit, R&D systems MAB835, 1:500), CPE (rabbit ...
-
bioRxiv - Microbiology 2022Quote: ... and anti-Tyro-3 (1:1000, R&D Systems, MAB859100) antibodies ...
-
bioRxiv - Neuroscience 2022Quote: ... washed 3× in 1× wash buffer (895003, R&D Systems), blocked in 1% BSA for 1 hour at room temperature (RT) ...
-
bioRxiv - Cancer Biology 2024Quote: ... polyclonal anti-caspase-3 (1:1000; R&D Systems GmbH), polyclonal anti-LC3 (1:1000 ...
-
P2RX7 inhibition reduces breast cancer induced osteolytic lesions - implications for bone metastasisbioRxiv - Cancer Biology 2022Quote: ... caspase-3 (R&D Systems, AF835), Endomucin (Santa Cruz ...
-
bioRxiv - Developmental Biology 2024Quote: ... 3 µM CHIR (R&D Systems), 10 mM A83-01 (Tocris ...
-
bioRxiv - Developmental Biology 2024Quote: ... SSEA-3 (R&D Systems, MAB1434) and Alexa Fluor 594 conjugated SSEA-4 (BioLegend ...
-
bioRxiv - Neuroscience 2024Quote: ... cultures were cotreated with 20 nM (2S,3S)-2-Amino-3-methyl-N-[2-(4-morpholinyl)ethyl]pentanamide dihydrochloride (LM11a-31)(R&D Systems, Minneapolis, MN, USA, Cat no: 5046) or vehicle solution consisting of DMSO during application of 6-OHDA ...
-
bioRxiv - Developmental Biology 2021Quote: ... rabbit anti-Active Caspase-3 (R&D Systems; AF835; 1:250); mouse anti-Mucin 5AC (Abcam ...
-
bioRxiv - Bioengineering 2022Quote: ... Immunohistochemical assays for Caspase 3 (1:1000, R&D systems, AF835), PDGFR-β (Santa Cruz Biotechnology ...
-
bioRxiv - Microbiology 2021Quote: ... 25 ng mL-1 IL-3 (203-GMP, R&D Systems), 2 mM GlutaMAX ...
-
bioRxiv - Cancer Biology 2023Quote: ... and IGFBP-3 (cat. no. AF675; R&D SYSTEMS, 1:1000) were used for Western blot analysis and Immunocytochemistry assays.
-
bioRxiv - Developmental Biology 2020Quote: ... and the combination treatment of Tgfb1/2/3 ligands (10ng/ml, each) (R&D systems, 240-B/302-B2/243-B3). At Day2 ...
-
bioRxiv - Microbiology 2021Quote: ... DY210) were quantified in the supernatants from uninfected and SARS-CoV-2-infected Calu-3 cells by ELISA (R&D Systems), following manufacturer’s instructions ...
-
bioRxiv - Cell Biology 2023Quote: ... anti-Galectin-3 (1:50; R&D systems, AF1197 & 1:100; Biolegend, 125401), anti-Hsp70 (1:300 ...
-
bioRxiv - Cell Biology 2020Quote: ... 3 ng/mL mFGF2 (R&D Systems), 1xITS (Millipore Sigma)) ...
-
bioRxiv - Bioengineering 2020Quote: ... cleaved caspase-3 (R&D System, MAB835) (1:150 in goat serum ...
-
bioRxiv - Genomics 2022Quote: ... 3 µM CHIR99021 (R&D Systems 4423), and 1 µM PD0325901 (Sigma PZ0162) ...
-
bioRxiv - Immunology 2021Quote: ... or recombinant ficolin-3 (R&D systems) or human purified C1q (Comp Tech ...
-
bioRxiv - Immunology 2020Quote: ... IFNλ2/3 ELISA (R&D Systems DY1789B) and mouse IFNβ ...
-
bioRxiv - Cell Biology 2021Quote: ... syndecan-3 (R&D Systems Cat#: FAB3539A) and syndecan-4 (R&D Systems Cat# ...
-
bioRxiv - Molecular Biology 2022Quote: ... 3 μM CHIR99021 (R&D Systems 4423), and 1 μM PD0325901 (Sigma PZ0162) ...